Glenmark set to launch FabiFlu 400mg for Covid-19 treatment in India
New Delhi: Glenmark Pharmaceuticals, a research-led global pharmaceutical company, Thursday announced that it is set to introduce a 400 mg ...
Read moreDetailsNew Delhi: Glenmark Pharmaceuticals, a research-led global pharmaceutical company, Thursday announced that it is set to introduce a 400 mg ...
Read moreDetailsNew Delhi: Glenmark Pharmaceuticals said Wedensday that the Phase 3 clinical trial of antiviral drug Favipiravir is giving hope. Glenmark ...
Read moreDetailsNew Delhi: Shares of Glenmark Pharmaceuticals on Monday tumbled nearly 6 per cent after India's drug regulator sought clarification from ...
Read moreDetailsNew Delhi: Drug firm Glenmark Pharmaceuticals said Monday it has cut price of antiviral drug ‘Favipiravir’. The drug is sold under ...
Read moreDetails
By Dilip Cherian What happens when the fence begins to eat the crop? In Delhi’s babu circles, this question is...
Read moreDetailsRoger Waters once wrote: Tide is turning; Satellite buzzing through the endless night; Exclusive to moonshots and world title fights;...
Read moreDetailsThe resignation of about 120 scientists and engineers from the Indian Space Research Organisation (ISRO), including those associated with top...
Read moreDetailsAs Parliament prepares to convene for the Monsoon Session on Monday, 20 July, the Modi government stands accused of shrinking...
Read moreDetails

